Clinical & translational oncology

• 

  Año 2025, Vol. 27, Número 7

  • REVIEW ARTICLE

    • Axillary lymph node management strategies in cN+breast cancer patients after neoadjuvant chemotherapy

      Min Gao, Xiaoxi Chen, Ling Xu

      • Resumen

      págs. 2769-2777

      

    • The evolving tumor‑associated adipose tissue microenvironment in breast cancer: from cancer initiation to metastatic outgrowth

      Yang Yang, Xiao Ma, Yue Li, Lihua Jin, Xianchun Zhou

      • Resumen

      págs. 2778-2788

      

    • Tp53 mutations and mdm2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds

      Rituraj Chakraborty, Anupam Dutta, Rupak Mukhopadhyay

      • Resumen

      págs. 2789-2800

      

    • Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles

      Faris Anad Muhammad, Farag Altalbawy, Viralkumar Mandaliya, Shelesh Krishna Saraswat, M. M. Rekha, Damanjeet Aulakh, Mamata Chahar, Morug Salih Mahd, Mohammed Adil Jaber, Merwa Alhadrawi

      • Resumen

      págs. 2801-2824

      

    • Gender and sex diferences in colorectal cancer screening, diagnosis and treatment

      Encarnación González Flores, Rocío García Carbonero, Elena Élez Fernández, Eduardo Redondo Cerezo, María José Safont, Ruth Vera García

      • Resumen

      págs. 2825-2837

      

    • Clinical implications of epithelial‑to‑mesenchymal transition in cancers which potentially spread to peritoneum

      Ludovico Carbone, Giosuè Giordano Incognito, Dalila Incognito, Lorenzo Nibid, Giuseppe Caruso, Massimiliano Berretta, Chiara Taffon, Marco Palumbo, Giuseppe Perrone, Franco Roviello, Daniele Marrelli

      • Resumen

      págs. 2838-2851

      

    • Targeting mitochondria and programmed cell death as potential interventions for metastatic castration‑resistant prostate cancer

      Amonlaya Amantakul, Akara Amantakul, Suwalee Pojchamarnwiputh, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn, Jirapas Sripetchwandee

      • Resumen

      págs. 2852-2875

      

    • Controversies in the use of next‑generation imaging for evaluation and treatment decision‑making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel

      Javier Maldonado Pijoan, Anna Boladeras, J. M. Gaya, Jesús Muñoz Rodríguez, J. Planas Morín, Gemma Sancho, Jose Francisco Suárez Crespo

      • Resumen

      págs. 2876-2888

      

    • Autologous tumor lysate‑loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature

      Siddharth Shah, Aiswarya Nag, Brandon Lucke Wold

      • Resumen

      págs. 2889-2903

      

    • Association of tumor treating felds (TTFields) therapy with overall survival in newly diagnosed glioblastoma

      Siddharth Shah, Aiswarya Nag, Brandon Lucke Wold

      • Resumen

      págs. 2904-2912

      

    • Biogenesis and functional implications of extracellular vesicles in cancer metastasis

      Sneha Sekar, Sandhya Srikanth, Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, Uddesh Ramesh Wanjari, Balachandar Vellingiri, Kaviyarasi Renu, Harishkumar Madhyastha

      • Resumen

      págs. 2913-2935

      

    • Pan‑cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer

      Camilly Victória Campanharo, Lívia Valle dos Santos Silveira, Débora Dummer Meira, Matheus Correia Casotti, Lorena Souza Castro Altoé, Iúri Drumond Louro, André Felipe Monteiro Gonçalves, André Manhães Machado, Breno Sousa Paiva, Ester de Souza Inocencio, Fabio Victor Vieira Rocha, Fellipe Pesente, Giulia de Souza Cupertino de Castro, João Pedro dos Santos da Paixão, José Henrique Borges Bourguignon, Júlia Salarini Carneiro, Juliana Ribeiro de Oliveira, Pâmela de Souza Freire, Sophia Bridi Zamprogno, Taissa dos Santos Uchiya, Thais de Paula Rezende, Vinícius de Pádua Sanders Medeiros

      • Resumen

      págs. 2936-2954

      

  • SPECIAL ARTICLE

    • Strategies to enhance management of HER2‑positive breast cancer in the elderly: an expert consensus perspective

      Sonia del Barco Berrón, Almudena Cotes Sanchís, Mercedes Cavanagh, Regina Gironés Sarrió, Borja López de San Vicente, Elena Galve Calvo, Sònia Servitja Tormo

      • Resumen

      págs. 2955-2969

      

  • RESEARCH ARTICLE

    • The role of the CXCL12/CXCR4 axis in the immunotherapy of non‑small cell lung cancer

      Jacobo Rogado Revuelta, Fernando Pozo, Kevin Troulé Lozano, María Pacheco, Magdalena Adrados, José Miguel Sánchez Torres, Fátima Al-Shahrour, Javier Aspa Marco, Arántzazu Alfranca González, Nuria Romero Laorden, Ramón Colomer Bosch

      • Resumen

      págs. 2970-2981

      

    • Preclinical study of TLR stimulation combined PD‑1 antibody enhance the therapeutic efect of microwave ablation on NSCLC

      Ying Yu, Fu Niu, Bo Sun, Shusen Zhang, Zhigang Cai

      • Resumen

      págs. 2982-2992

      

    • Clinical characteristics and survival outcomes in patients with pulmonary sarcomatoid carcinoma: a multicenter retrospective study

      Zhijuan Du, Yuhui Qin, Yahui Lv, Jie Gao, Siyuan Chen, Xiangyu Du, Tao Li, Yi Hu, Zhefeng Liu

      • Resumen

      págs. 2993-3000

      

    • Ethnic disparities in survival and progression among EGFR‑mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta‑analysis

      Francisco Cezar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Eric Pasqualotto, Jessica Fernanda Cassemiro, Jhonny Wilson Limachi Choque, Rommel Mario Rodríguez Burbano

      • Resumen

      págs. 3001-3014

      

    • Predictive signifcance of MPT‑driven necrosis‑related genes signature in gastric cancer and their impact on the tumor microenvironment

      Silan Huang, Lingli Huang, Qi Jiang, Chang Jiang, Guifang Guo

      • Resumen

      págs. 3015-3028

      

    • Pan‑cancer analysis reveals the prognostic and immunomodulatory potential of super‑enhancer‑induced ANGPT2 and experimental validation in colorectal cancer

      Songyue Guo, Yanan Yu, Yulan Bu, Jiao Ren, Lu Zhang, Xiaolin Ma, Jiaqiu Li, Ao Li, Xinling Liu

      • Resumen

      págs. 3029-3057

      

    • Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach

      Eva Muñoz Couselo, Javier Cañueto Álvarez, Vanessa Gabriela Jerviz Guía, Ana María López López, Oriol Bermejo Segú, Almudena García Castaño, Susana Puig Sardá, Onofre Sanmartín Jiménez, Ainara Soria, Paula Gratal, María Teresa Pardo Moreno, Álvaro Rogado, Alfonso Berrocal Jaime

      • Resumen

      págs. 3058-3072

      

    • PMN‑MDSCs are responsible for immune suppression in anti‑PD‑1 treated TAP1 defective melanoma

      Xiao Zhang, Kaijun Sun, Bingzheng Zhong, Likun Yan, Pengrui Cheng, Qiang Wang

      • Resumen

      págs. 3073-3083

      

    • LAG‑3 and TIM‑3 expression in melanoma and histopathological correlation: a single‑center study

      Mine İlayda Şengör Aygün, Özben Yalçın

      • Resumen

      págs. 3084-3099

      

    • Azathioprine and risk of non‑melanoma skin cancers in organ transplant recipients: a systematic review and update meta‑analysis

      Michele Kreuz, Jorge Cavalcanti Orestes Cardoso, Luis Eduardo Rodrigues Sobreira, María Eduarda Di Cavalcanti Alves de Souza, Lara Eduardo Campos, Francinny Alves Kelly, Francisco Cezar Aquino de Moraes

      • Resumen

      págs. 3100-3109

      

    • Evaluating the prognostic role of glucose‑to‑lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in frst line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)

      Hatice Bölek, Omer Faruk Kuzu, Elif Sertesen Camoz, Saadet Sim, Serhat Sekmek, Hilal Karakaş, Selver Isık, Murat Günaltılı, Aysun Fatma Akkus, Deniz Tural, Cagatay Arslan, Sema Sezin Goksu, Ozlem Nuray Sever, N. Karadurmus, Cengiz Karacin, Mehmet Ali Nahit Sendur, Emre Yekedüz, Yüksel Ürün

      • Resumen

      págs. 3110-3120

      

    • Prognostic value of HER2 2 + expression in patients with TNBC receiving adjuvant capecitabine

      Tuğba Önder, Muhammet Cengiz, Sıla Soylu Koçoğlu, Öztürk Ateş, Ozan Yazici, Mevlüde İnanç, Ayşe Ocak Duran

      • Resumen

      págs. 3121-3129

      

    • Five‑year results of a prospective trial of IORT‑photon boost and hypofractionated whole‑breast irradiation after breast‑conserving surgery

      J. Burgos Burgos, Víctor Vega Benítez, David Macias Verde, E. Vicente, C. Murias, C. Santana, Ramón Eduardo Téllez Uzcategui, Pedro Lara Jiménez

      • Resumen

      págs. 3130-3134

      

    • Ultra‑hypofractionated 5‑fraction radiation therapy for early breast cancer into whole breast and regional nodes: experience in a tertiary hospital

      Eva María Tejada Ortigosa, Inés Ollinger Casin, Isabela Gaztelu Blanco, Gema Muñiz Romero, Roberto de Haro Piedra

      • Resumen

      págs. 3135-3143

      

    • SABR tolerance after prostatectomy: pushing the boundaries of ultrahypofractionation

      Angel Montero, Ovidio Hernando Requejo, Mercedes López, Jeannette Josefina Valero Albarrán, Raquel Ciérvide Jurío, Emilio Sánchez Saugar, Alejandro Prado, Helena B. Zobec, X. Chen Zhao, Beatriz Álvarez, Mariola García Aranda, Leyre Alonso Iracheta, Rosa Alonso, Pedro Fernández Letón, C. Rubio Rodríguez

      • Resumen

      págs. 3144-3153

      

    • PSA bounce: understanding temporal fuctuations in prostate cancer after external radiotherapy

      Nicolás Feltes, Joan Lozano Galán, Carlos G. Forero, Montserrat Colomer Truyols, Saturio Paredes, E. Jovell Fernández

      • Resumen

      págs. 3154-3162

      

    • Expression of vesiculation‑related genes is associated with a tumor‑promoting microenvironment: a pan‑cancer analysis

      Luisa Westermann, Brenda Diergaarde, Simon Heidegger, Hendrik Poeck, Mirosław J. Szczepański

      • Resumen

      págs. 3163-3174